Beneficial effect of Brewers' yeast extract on daily activity in a murine model of chronic fatigue syndrome

Evidence-based Complementary and Alternative Medicine

Volumn 3, Issue 1, 2006, Pages 109-115

  Takahashi, Takashi ^a   Yu, Fei ^a   Zhu, Shi Jie ^a   Moriya, Junji ^a   Sumino, Hiroyuki ^b   Morimoto, Shigeto ^a   Yamaguchi, Nobuo ^a   Kanda, Tsugiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Brewers' yeast extract; Chronic fatigue syndrome; Daily activity; Spleen

Indexed keywords

ALANINE; ARGININE; ASPARTIC ACID; BACTERIAL ANTIGEN; CYSTINE; GAMMA INTERFERON; GLUTAMIC ACID; GLUTATHIONE; GLYCINE; HISTIDINE; INTERLEUKIN 10; ISOLEUCINE; LEUCINE; LYSINE; MESSENGER RNA; METHIONINE; NATURAL PRODUCT; PANTOTHENIC ACID; PHENYLALANINE; PROLINE; RIBOFLAVIN; SERINE; THIAMINE; THREONINE; TRYPTOPHAN; TYROSINE; VALINE; ZINC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BRUCELLA ABORTUS; CHRONIC FATIGUE SYNDROME; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; RUNNING; SACCHAROMYCES CEREVISIAE; SPLEEN WEIGHT; SURVIVAL; TREATMENT OUTCOME;

EID: 33745684495     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1093/ecam/nek012     Document Type: Article

References (22)

1. Krupp LB, LaRocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
2. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989;1:1122-6.
3. Chao CC, Strgar F, Tsang M, Peterson PK. Effects of swimming exercise on the pathogenesis of acute murine Toxoplasma gondii Me49 infection. Clin Immunol Immunopathol 1992;62:220-6.
4. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med 1994;121:953-9.
5. Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med 1988;108:387-9.
6. Chao CC, DeLaHunt M, He S, Close K, Peterson PK. Immunologically mediated fatigue: A murine model. Clin Immunol Immunopathol 1992;64:161-5.
7. Ottenweller JE, Natelson BH, Cause WC, Carroll KK, Beldowicz D, Zhou XD, et al. Mouse running activity is lowered by Brucella abortus treatment: a potential model to study chronic fatigue. Physiol Behav 1998;63:795-801.
8. Wang XQ, Takahashi T, Zhu SJ, Moriya J, Saegusa S, Yamakawa J, et al. Effect of Hochu-ekki-to (TJ-41), a Japanese herbal medicine, on daily activity in a murine model of chronic fatigue syndrome. Evid Based Complement Alternat Med 2004;1:203-6.
9. Svetic A, Jian YC, Lu P, Finkelman FD, Gause WC. Brucella abortus induces a novel cytokine gene expression characterized by elevated IL-10 and IFN-γ in CD4+ T cells. Int Immunol 1993;5:877-83.
10. Gerhauser C. Beer constituents as potential cancer chemopreventive agents. Eur J Cancer 2005;41:1941-54.
11. Puri BK, Holmes J, Hamilton G. Eicosapentaenoic acid-rich essential fatty acid supplementation in chronic fatigue syndrome associated with symptom remission and structural brain changes. Int J Clin Pract 2004;58:297-9.
12. Nakagawasai O, Tadano T, Yasue M. Effect of brewers yeast extract on a physical fatigue-induced stress in mice. Presentation abstracts of the 58th annual scientific meeting: the Japanese Society of Nutrition and Food Science 2004,265.
13. Kanda T, McManus JEW, Nagai R, Imai S, Suzuki T, Yang DC, et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res 1996;78:848-56.
14. Dotsenko VA, Mosiichuk LV, Paramonov AE. Biologically active food additives for correction of the chronic fatigue syndrome. Vopr Pitan 2004;73:17-21.
15. Sacks N, Van Rensburg AJ. Clinical aspects of chronic brucellosis. S Afr Med J 1976;50:725-8.
16. Oth D, Sabolovic D, Le Garrec Y. Genetic (h-2) dependence of the duration of splenomegaly induced by Brucella abortus. Folia Biol (Praha) 1974;20:20-5.
17. Demetropoulos KC, Lindenauer SM, Rapp R, Robins J. Target calcifications of the spleen in chronic brucellosis (Brucella suis). J Can Assoc Radio 1974;25:161-3.
18. Riglar C, Cheers C. Macrophage activation during experimental murine brucellosis. II. Inhibition of in vitro lymphocyte proliferation by brucella-activated macrophages. Cell Immunol 1980;49:154-67.
19. Cox IM, Campbell MI, Dowson D. Red blood cell magnesium and chronic fatigue syndrome. Lancet 1991;337:757-60.
20. Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurol Scand 1999;99:112-6.
21. Kaslow JE, Rucker L, Onishi R. Liver extract-folic acid-cyanocobalamin vs placebo for chronic fatigue syndrome. Arch Intern Med 1989;149:2501-3.
22. Grumbach IM, Chen W, Mertens SA, Harrison DG. A negative feedback mechanism involving nitric oxide and nuclear factor kappa-B modulates endothelial nitric oxide synthase transcription. J Mol Cell Cardiol 2005;39:595-603.